Toujeo 300 units/ml SoloStar

DRUG2 trials

Sponsors

University Medical Center Utrecht, Novo Nordisk A/S

Conditions

Type 2 diabetesType 2 diabetes mellitus (T2DM)

Phase 4

Pan-European proof-of-concept study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes mellitus treated with Toujeo®

CompletedCTIS2022-500449-26-00

University Medical Center UtrechtType 2 diabetes mellitus (T2DM)

Start: 2023-08-03End: 2024-11-19Target: 500Updated: 2024-08-12

EFFectiveness of once-weekly insulin ICodec versus once-daily basal Insulin analogues in an insulin-naïve type 2 diabEtes population in real-world cliNical pracTice- The EFFICIENT pragmatic study

Not yet recruitingCTIS2024-520068-32-00

Novo Nordisk A/SType 2 diabetes

Target: 204Updated: 2026-01-12